Melanoma: open trials in Argentina

3 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
CABA
Registry updated 2026-11-03
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Hospital Alemán, Buenos Aires · DIABAID, Buenos Aires · Hospital Sirio Libanes, Caba · Centro Médico Austral, Ciudad Autonoma Buenos Aires · Centro de Investigaciones Medicas y Desarrollo LC SRL (LC Investigacion), Ciudad Autonoma Buenos Aires · Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata
Registry updated 2026-10-26
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Trial Treatment · Phase 3 · Immunocore Ltd
Hospital Italiano de Buenos Aires (HIBA), Buenos Aires · Sanatorio Finochietto, Caba · Clínica Adventista Belgrano - Sector Investigación, Caba · Instituto Alexander Fleming, CABA · Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba · Clínica Viedma, Viedma
Registry updated 2026-02-25

This page is not medical advice. Talk to your doctor before contacting a trial.

Dabrafenib and/or Trametinib Rollover Study